We describe a method for the diagnosis of mitochondrial fatty acid oxidation disorders that is based on the analysis of acylcarnitine and acyl-coenzyme A (acyl-C0A) esters generated during fatty acid oxidation by permeabilized skin fibroblasts. This method requires only small amounts of cultured flbroblasts with minimal preparation, and no isolation of mitochondrial fractions is necessary. During oxidation of [U-14C]hexadecanoate, normal human fibroblasts produce a characteristic pattern of acylcarnitine and acyl-CoA ester intermediates. Incubations of flbroblasts from patients with fatty acid oxidation defects show a completelydifferent patternof intermediates, and in each case the observed profile reflects the siteof the defect. The diagnosis and likely site of a mitochondrial fatty acidoxidation defectcan be made readily from two 80-cm2 culture flasks offibroblasts withthis technique.
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In humans, long-chain fatty acids constitute a major source of energy, especially for skeletal muscle, heart, and liver. In skeletal muscle, fatty acid oxidation is the major source of energy both in the resting state (1) and during prolonged exercise.
In the myocardium, longchain fatty acids are the preferred substrate in the resting state (2). In the liver, during fasting, fatty acid oxidation produces ketone bodies, which are oxidized by extrahepatic tissues 
Preparation of Fibroblasts
Fibroblasts from two 80-cm2 flasks were harvested by trypsinization, washed twice with 10 mL of phosphatebuffered saline, and resuspended in 0.7 mL of medium containing 250 mmolJL sucrose, 3 mmoljL EDTA, and 20 mmol/L HEPES, pH 7.4, in a 1.5-mL microcentriflige tube. The cell suspension was centrifuged (avg. 12 000g) for 1 min; the pellet was then resuspended in 0.5 mL of incubation medium and recentrifuged (avg. 12000g,45 s). Finally the pellet was resuspended in 1.0 mL of incubation medium and used directly for the measurement of (3-oxidation flux and intermediates.
Protein concentration and activities of citrate synthase and lactate dehydrogenase were determined according to standard procedures (33) (34) (35) .
Incubationwith [U-14C]Hexadecanoate
Incubations were made in 1 mL of medium containing 
Radio-HPLC Analysis of AcyI-C0A Esters
Acyl-C0A esters were extracted from the fibroblast incubations and analyzed by radio-HPLC as described previously (25) 
Radio-HPLC Analysisof AcylcarnitineEsters
Acylcarnitines were extracted as described previously (25) except that undecanoylcarnitine was used as internal standard. was detected on-line as described (25, 37) except that the scintillation fluid was methanol:Ecosint A (National Diagnostics, Atlanta, GA)(1:2 by vol). The identity of each acyl-CoA and acylcarnitine ester generated during the fibroblast incubations was determined by its relative retention time compared with those of standard compounds. Quantification was based on the integrated radioactive peaks (37) after correction for recovery with appropriate internal standard.
Results
Preparationof Permeabilized Fibroblasts
In preliminary experiments we investigated whether intact cultured human skin fibroblasts were suitable for studies on mitochondrial fatty acid oxidation. Although intact cells were able to oxidize [U-'4C}hexadecanoate, as measured by the release of '4C02 or acid-soluble radioactivity, no intermediates could be detected when these incubations were analyzed for U-'4C-labeled acyl-CoA or acylcarnitune esters by radio-HPLC. This was the case for cell lines from both normal individuals and patients with proven defects of mitochondrial fatty acid oxidation. It was, therefore, necessary to permeabilize the plasma membrane to allow greater access to substrate and L-carnitine. This can promote the formation of acylcarnitine esters and allow distribution of these intermediates throughout the whole incubation medium. Among the methods evaluated to selectively permeabilize the plasma membrane while maintaining intact mitochondria were hand homogenization, centrifugation, and the use of permeabilizing reagents such as digitonin (38) , saponin (39), and histone 11-AS. The degree of penneabilization was assessed by monitoring the release of marker enzymes from the cytosol (lactate dehydrogenase) and mitochondrial matrix (citrate synthase). Each cell preparation was also incubated with fiU-'4C]hexadecanoate and acyl-CoA, and the acylcarrntine ester intermediates generated were analyzed to assess which preparation produced the same pattern of intermediates as seen in isolated intact mitechondria from fibroblasts (22). Two preparations proved suitable: histone-treated fibroblasts (1.5 g/L histone H-AS for 1 mm), and those disrupted by mechanical forces during centrifugation (12 000g for 60 s, followed by 12 000g for 45s). All subsequent experiments were carried out in duplicate with the above two preparations.
No differences were observed between the two sets of experiments, and the data on fibroblasts prepared by using the latter procedure are presented here because of the simplicity of the preparation.
The percentage recovery of citrate synthase measured in four different preparations ranged from 94% to 98%, indicating that most of the mitochondria remain intact, whereas 60% to 65% of lactate dehydrogenase was released into the supernate.
Reproducibility of Incubations with Permeabilized
Fibroblasts
The reproducibffity of the incubations with permeabilized fibroblasts was examined by preparing a permeabilized preparation of fibroblasts on three separate occasions from the same cell line. Incubations with [U-'4C]hexadecanoate were performed, the /3-oxidation rate was measured, and each acyl-CoA and acylcarnitine ester was quantitated.
The rates of flux through /3-oxidation, as measured by the production of acid-soluble metabolites, were 33.5, 31.6, and 29.3 for a control cell line and 20.7, 20.0, and 18.8 (anol/g protein per hour) for a trifunctional enzyme-deficient cell line in three experiments. The analysis of acyl-CoA and acylcarnitine intermediates from these incubations revealed a CV of 10-20% for each ester. We also measured the contribution of peroxisomal /3-oxidation in these incubations.
The data presented in Fig. 1 
Flux and Intermediatesof Fatty Acid Oxidationin Normal Fibroblasts
The rate of flux through /3-oxidation, as measured by the production of acid-soluble radioactivity from [U-'4Clhexa-decanoate, was 34.8 ± 7.0 pmoVg protein per hour (mean ± SD, n = 6) in normal fIbroblasts ( Fig. 3A) . (Fig. 2D) . Analysis of the acylcarnitine esters showed a similar but more pronounced pattern, with the accumulation of 3-hydroxytetradecanoylcarnitine, 3-hydroxyhexadecanoylcarnitune, tatradec-2-enoylcarnitine, and hexadec-2-enoylcarnitine, and decreased concentrations of chain-shortened products, acetylcarnitine, octanoylcarnitine, and decanoylcarnitine (Table 2 ; Fig. 3D ). The pattern and amount of acyl-CoA and acylcarnitine esters generated in the cell lines from six patients with tnifunctional enzyme deficiency were very similar (Table 2 ) despite evidence for biochemical and molecular heterogeneity in these pa-
tients (Jackson et al., ms. in preparation). MCAD deficiency.
The production of acid-soluble metal> olites from the oxidation of [LJ-'4C]hexadecanoate in cell lines from patients with MCAD deficiency was 90% of mean control values. This apparently normal rate is due to the overlapping chain-length specificities of the acyl-CoA dehydrogenases and the fact that medium-chain acyl-CoA and acylcarnitmne esters are acid soluble. In all cell lines, the concentration of hexadecanoyl-CoA was normal. The concentrations of tetradecanoyl-CoA and dodecanoyl-CoA were decreased, whereas those of decanoyl-CoA and cctanoyl-CoA were increased (Fig. 2B) . A similar pattern was seen for the acylcarnitine esters: the concentrations of decanoylcarnitine and octanoylcarnitine were highly increased; those of dodecanoylcarnitine, tetradecanoylcarnitine, and hexadecanoylcarnitune were normal; and hexanoylcarnitine and butyrylcarnitine were not detected ( Table 2 ; Fig. 3B ). In these fibroblasts we observed slightly and their corresponding carnitine esters. No chain-shortened acyl-CoA or acylcarnitine esters shorter than C14 were detected, and the generation of acetylcarnitine was significantly reduced (Table 2 ; Figs. 2C and 3C) . CPT H deficiency. Acid-soluble metabolites formed during the oxidation of [U-'4Clhexadecanoate in the two cell lines with CPT II deficiency were surprisingly normal under the conditions used (Table 1) . This apparently normal rate is presumably because the sum of the accumulated acid-soluble chain-shortened intermediates (i.e., C2-C10) is similar to that of controls (Table 2 ; Fig. 3E ). In both cell lines hexadecanoyl-CoA was the only detectable acylCoA ester and its concentration was normal (patients, 2.1 and 2.6 p.mollg protein per hour; controls, 2.64 ± 0.64, mean ± SD, n =6; Fig. 2E ). The concentration of hexadecanoylcarnitine is considerably increased, and tetradecanoylcarnitine, dodecanoylcarnitine, and decanoylcarnitine are not detected, whereas the concentrations of short-chain acylcarnitines (i.e., C4-C8) and particularly acetylcarnitine are increased (Table 2, Fig. 3E ). The finding of high concentrations of acetylcarnitine in the incubations of these cell lines is surprising and presumably results from inhibition of the further oxidation of acetylcarrntine.
CPT I deficiency. Flux through 13-oxidation was im-paired, and the rate of formation of acid-soluble metabolites from [TJ-'4C]hexadecanoate was 53% of mean control values (Table 1 ). The analysis of intermediates from this cell line showed a characteristic pattern: Hexadecanoyl-CoA was the only acyl-CoA detected and its concentration was highly increased (patient, 7.6 nnoIJg protein per hour; controls, 2.64 ± 0.64 mean ± SD, n = 6; Fig. 2F ), whereas hexadecanoylcarnitine was present in very small amounts (20% of mean control values; Table 2 ). Acetylcarnitine production was reduced and tetradecanoylcarnitine and dodecanoylcarrntine were not detectable, whereas acylcarnitine esters with chainlengths C2-C10 were present (Table 2; Fig. 3F) .
Carnitine-acylcarnitine translocase deficiency. Flux through /3-oxidation was impaired and the rate of formation of acid-soluble metabolites from [U-'4C]hexadecanoate was 17% of mean control values ( Table 1) . The concentration of hexadecanoyl-CoA was slightly reduced in the incubation of this cell line (patient, 2.02 imol/g protein per hour; controls, 3.04 ± 0.64, mean ± SD, n = 6) and no acyl-CoA ester shorter than C16 was detected.
The concentration of hexadecanoylcarnitine, however, was grossly increased, whereas those of tetradecanoylcarnitine and dodecanoylcarnitine were reduced. No acylcarnitine shorter than C10 was detectable, and acetylcarnitine concentration was low ( Table  2) . However, small amounts of 2,3-hexadecenoylcarnitine and 3-hydroxyhexadecanoylcarnitine were present, although the site of formation of these intermediates is uncertain.
DIscussIon
The diagnosis of disorders of mitochondrial fatty acid oxidation remains difficult. In fibroblasts, assessment of the pathway by measuring the release of CO2 or acidsoluble radioactivity from U-'4C-labeled fatty acids (40) (41) (42) 
